Literatur
-
1
Brennan M F.
PET
scanning in malignancy: infant, adolescent or mature citizen.
Ann Surg.
2001;
233
320-321
-
2
Brücher B LDM, Weber W, Bauer M, Fink U, Avril N, Stein H J, Werner M, Zimmermann F, Siewert J R, Schwaiger M.
Neoadjuvant
therapy of esophageal squamous cell carcinoma: response evaluation
by positron emission tomography.
Ann Surg.
2001;
233
300-309
-
3
Dt Ges Nuklearmedizin .
Konsensus
-Onko PET.
Nuklearmedizin.
1997;
36
45-46
-
4
Dietlein M, Weber K, Gandjour A, Moka D, Theissen P, Lauterbach K W, Schicha H.
Cost-effectiveness
of FDG-PET for the management of potentially operable non-small
cell lung cancer: priority for a PET-based strategy in nodal-negative
CT results.
Eur J Nucl Med.
2000;
27
1598-1609
-
5
Franke J, Rosenzweig S, Reinartz P, Höer J, Kasperk R, Schumpelick V.
Die
Wertigkeit der Positronen-Emissionstomographie (18F-FDG-PET) in
der Diagnostik von Rectum-Rezidivcarcinomen.
Chirurg.
2000;
71
80-85
-
6
Franzius C, Schulte M, Hillmann A, Winkelmann W, Jürgens H, Bockisch A, Schober O.
Klinische
Wertigkeit der Positronen-Emissionstomographie (PET) in der Diagnostik
der Knochen- und Weichteiltumore.
Chirurg.
2001;
72
1071-1077
-
7
Gambhir S S, Shepard J E, Shah B D, Hart E, Hoh C K, Valk P E, Emi T, Phelps M E.
Analytical
decision model for the cost-effective managment of solitary pulmonary
nodules.
J Clin Oncol.
1998;
16
2113-2125
-
8
McKinley J B.
From
promising reports to standard procedure: stages in the career of
a medical innovation.
Milbank Man Fund.
1981;
59
374
-
9
Park K C, Schwimmer J, Shepherd J E, Phelps M E, Czernin J R, Schiepers C h, Gambhir S S.
Decision
analysis for the cost-effectice management of recurrent colorectal
cancer.
Ann Surg.
2001;
233
310-319
-
10
Price P.
Positron
emission tomography (PET) in diagnostic oncology: is it a necessary
tool today?.
Eur J Cancer.
2000;
36
691-693
-
11
Reske S N, Bares R, Büll U, Guhlmann A, Moser E, Wannenmacher M F.
Clinical
value of positron emission tomography (PET) in oncologic questions:
results of an interdisciplinary consensus conference.
Nuklearmedizin.
1996;
35
42-52
-
12
Reske S N, Kozerke J. et al .
Results
of the 3rd German interdisciplinary consensus conference »Onko-PET
III«.
Eur J Nucl Med.
(im Druck)
-
13
Rothmund M.
Fortschritte
in der Chirurgie - Fortschritt in den Köpfen (Kommentar).
Dtsch
Med Wochenschr.
2001;
126
481-482
-
14
Schürmann G, Franzius C h, Twelker L, Senninger N, Schober O.
Die
Rolle der FDG-PET in der onkologischen Chirurgie.
Chirurg.
2001;
72
528-536
-
15
Staib L, Schirrmeister H, Reske S N, Beger H G.
Is
(18)F-fluorodeoxyglucose positron emission tomography in recurrent
colorectal cancer a contribution to surgical decision making?.
Am
J Surg.
2000;
180
1-5
-
16
Strasberg S M, Dehdashti F, Siegel B A, Drebin J A, Linehan D.
Survival
of patients evaluated by FDG-PET before hepatic resection for metastatic
colorectal carcinoma: a prospective database study.
Ann
Surg.
2001;
233
293-299
-
17
Zimny M, Schumpelick V.
Fluordeoxyglukose
Positronenemissionstomographie (FDG-PET) zur Dignitätsbeurteilung
von Läsionen des Pankreas.
Chirurg.
2001;
72
989-994
Univ. Prof. Dr. med. U. Büll
Klinik für Nuklearmedizin der RWTH
Aachen, Universitätsklinikum
Pauwelsstraße 30
52057 Aachen
Email: buell@nuk-gate.nukmed.rwth-aachen.de
Univ. Prof. Dr. med. Dr. rer. nat. O. Schober
Klinik und Poliklinik für Nuklearmedizin
der Universität Münster
Albert-Schweizer-Str. 33
48129 Münster
Email: schober.otmar@uni-muenster.de
Univ. Prof. Dr. med. R. Osieka
Medizinische Klinik IV (Hämatologie
und Onkologie) der RWTH Aachen
Pauwelsstraße 30
52057 Aachen
Email: rainhardt.osieka@post.rwth-aachen.de
